Company lists · Data refreshed September 2026

Top 13 Immunotherapy venture capital companies based in San Francisco, United States

RevenueBase identified 26 immunotherapy venture capital companies headquartered in San Francisco, United States as of September 2026 and tracks 293 professional contacts across them, including 126 with verified work emails. Cambridge is the largest hub.

This list covers immunotherapy venture capital companies headquartered in San Francisco, United States, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, how directly it supports the match, and when it was last checked. Data refreshed September 3, 2026.

Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase SmartSearch, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.

How to read this list HQ checked on every row Match evidence on every row Refreshed Sep 3, 2026 86% judged on-target in blind review
26Companies
293Contacts tracked
126Verified emails
Unlock all 26 companies Free signup · no credit card · 500 free credits

The 13 largest immunotherapy venture capital companies based in San Francisco, United States

Ranked by team size
Top 13 of 26 immunotherapy venture capital companies based in San Francisco, United States, ranked by team size, largest first. Data refreshed Sep 3, 2026. Evidence rates how directly each company's own description names immunotherapy venture capital companies: strong (names it), partial (names part of it), indirect (matched on its full profile rather than the summary shown). Click a count to unlock that company's people.
#CompanyHeadquartersEmployeesContacts
1
Versant VenturesPartial evidence
San Francisco, CA, United StatesHQ checked Sep 3, 202611-5061

“Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies.”

Source: company website · checked Sep 3, 2026
2San Francisco, CA, United StatesHQ checked Sep 3, 202611-5038

“For decades, entrenched infrastructure barriers have slowed progress in the fight against cancer and the development of potent immunotherapies.”

Source: company website · checked Sep 3, 2026
3
Triumvira Immunologics, INCIndirect evidence
San Francisco, CA, United StatesHQ checked Sep 3, 202611-5030

“At Triumvira Immunologics, Inc, our team is dedicated to a vision of finding a cure and providing new hope for patients with life-threatening disease.”

Source: company website · checked Sep 3, 2026
4
YosemitePartial evidence
San Francisco, CA, United StatesHQ checked Sep 3, 202611-5026

“Yosemite is an oncology-focused venture fund investing in biotech and healthcare innovations to make cancer non-lethal.”

Source: company website · checked Sep 3, 2026
5
Shennon BiotechnologiesIndirect evidence
San Francisco, CA, United StatesHQ checked Sep 3, 202611-5017

“ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which…”

Source: company website · checked Sep 3, 2026
6
GigamuneIndirect evidence
San Francisco, CA, United StatesHQ checked Sep 3, 20261-1011

“GigaMune is a therapeutics company developing a novel technology for in vivo, T cell targeted gene delivery of T cell receptors (TCRs) and chimeric antigen receptors (CARs) for…”

Source: company website · checked Sep 3, 2026
7
Siren BiotechnologyIndirect evidence
San Francisco, CA, United StatesHQ checked Sep 3, 20261-106

“The fight against cancer needs new, big, bold ideas.”

Source: company website · checked Sep 3, 2026
8
Kopra BIOPartial evidence
San Francisco, CA, United StatesHQ checked Sep 3, 20261-106

“Kopra Bio makes cancer cures using viral immunotherapy technology we developed at UCSF.”

Source: company website · checked Sep 3, 2026
9
babel.venturesPartial evidence
San Francisco, CA, United StatesHQ checked Sep 3, 20261-106

“BABEL Ventures is leading the charge in early-stage consumer biotech investments.”

Source: company website · checked Sep 3, 2026
10
Avail BIOPartial evidence
San Francisco, CA, United StatesHQ checked Sep 3, 20261-104

“Avail Bio is a venture-backed genomic biotechnology company in San Francisco, CA.”

Source: company website · checked Sep 3, 2026
11
Codon CapitalStrong evidence
San Francisco, CA, United StatesHQ checked Sep 3, 20261-102

“Codon Capital is a San Francisco-based biotech venture capital company, specializing in therapeutics and synthetic biology.”

Source: company website · checked Sep 3, 2026
12
Scribe BiosciencesPartial evidence
San Francisco, CA, United StatesHQ checked Sep 3, 20261-101

“Scribe Biosciences is an early-stage company pioneering technologies to accelerate immunotherapy discoveries through linked functional and genomic profiling of single-cell…”

Source: company website · checked Sep 3, 2026
13
Foundery Innovations, INCIndirect evidence
San Francisco, CA, United StatesHQ checked Sep 3, 20261-101
Source: company website · checked Sep 3, 2026

Showing 13 of 26 immunotherapy venture capital companies based in San Francisco, United States

See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 126 reachable decision-makers.

Free signup · no credit card

See all 26 companies

Immunotherapy venture capital companies based in San Francisco, United States at a glance

As of Sep 3, 2026
1-10Median size (employees)
CambridgeLargest hub · 50 HQs
Contacts with mobile numbers
Sep 3, 2026Data refreshed

Companies by employee count

1-10
18
11-50
8

Email recency for this list is measured across the whole United States list rather than this city, so it is reported there. Company counts and contact totals on this page are exact for San Francisco, over 26 companies.

How this list was built

Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among immunotherapy venture capital companies, so some rows will be adjacent to the category rather than pure plays. The description and evidence rating on every row are there so you can check each match yourself.

Source
The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase SmartSearch, the natural-language company search available to every RevenueBase user.
What qualifies
Companies headquartered in San Francisco, United States whose own description of what they do matches “immunotherapy venture capital companies”. Matching reads each company's description, not its industry code or its name.
What we exclude
Companies whose own description does not clearly place them among immunotherapy venture capital companies, and records with no verified work email. Companies headquartered outside San Francisco are excluded even when they keep an office there.
Match quality
In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and an evidence rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
Ranking
Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
Verification
Every listed company carries at least one verified work email, 126 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
Refresh
This page's figures were pulled from the company graph on September 3, 2026. Lists refresh periodically as the graph is re-checked.
Corrections
Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.

Frequently asked

How many immunotherapy venture capital companies are there based in San Francisco, United States?

RevenueBase identified 26 immunotherapy venture capital companies headquartered in San Francisco, United States as of September 2026, matched on each company's own description of what it does rather than its industry code.

What is the largest company on this list?

Versant Ventures, headquartered in San Francisco, tops this list with the largest team on record.

Which city has the most immunotherapy venture capital companies?

Cambridge leads with 50 headquartered companies, followed by San Diego (49) and Boston (39).

How do I get contact information for these companies?

A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 126 verified decision-maker contacts tracked across these 26 companies.

How current is this list?

The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 3, 2026.

Ready to reach these companies? Verified emails and direct dials for all 26 immunotherapy venture capital companies based in San Francisco, United States. Start with a free account, no credit card.

Get the full list

Related lists

About this data

RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase SmartSearch, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.